33 assets in Acute Undifferentiated Leukemia

Therapeutic assets addressing Acute Undifferentiated Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fludarabine Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	BB (71)
Cyclophosphamide Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (70)
Cytarabine Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P3	BB (70)
Dexasone Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	BB (70)
Nivestim Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P3	BB (70)
Daunomycin Acute Undifferentiated Leukemia	Syndax Pharmaceuticals	P3	BB (68)
Etoposide Acute Undifferentiated Leukemia	Syndax Pharmaceuticals	P3	BB (68)
Methotrexate Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	BB (68)
Pegaspargase Acute Undifferentiated Leukemia	Syndax Pharmaceuticals	P3	BB (68)
Busulfanum Acute Undifferentiated Leukemia	Ossium Health, Inc.	P2	BB (67)
Cyclosporin A Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	BB (67)
Idarubicin Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	BB (67)
Prednisone Acute Undifferentiated Leukemia	Syndax Pharmaceuticals	P3	BB (65)
Hydrocortisone Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	BB (64)
(+)-Vincristine Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P2	B (63)
Allopurinol Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Mesna Acute Undifferentiated Leukemia	Ossium Health, Inc.	P2	B (62)
Sirolimus Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Thiotepa Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	B (62)
Tacrolimus Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	B (61)
Orca-T Acute Undifferentiated Leukemia	Orca Biosystems, Inc.	P3	B (60)
Decitabine Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P1/2	CC (47)
Orca-Q Acute Undifferentiated Leukemia	University of Florida	P1/2	CC (47)
Revumenib Acute Undifferentiated Leukemia	Syndax Pharmaceuticals	P1	CC (46)
Azacitidine Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Cladribine Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Exercise Mobilized Prophylactic Dli Acute Undifferentiated Leukemia	University of Arizona	P1	CC (43)
Mitoxantrone Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Tagraxofusp Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P1	CC (43)